Odyssey Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for autoimmune and inflammatory diseases. The company's strategy involves targeting upstream signaling nodes in the innate immune system to prevent pathological inflammation before it starts, aiming to induce long-lasting remission for patients.
Company Values
The company differentiates itself by focusing on upstream mechanisms of the innate immune system to preemptively halt inflammation, rather than treating its downstream effects.